Co-administration of memantine has no effect on the in vitro or ex vivo determined acetylcholinesterase inhibition of rivastigmine in the rat brain
- 30 September 2004
- journal article
- research article
- Published by Elsevier in Neuropharmacology
- Vol. 47 (3) , 408-413
- https://doi.org/10.1016/j.neuropharm.2004.04.009
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- A simple, rapid and sensitive method for simultaneous determination of rivastigmine and its major metabolite NAP 226‐90 in rat brain and plasma by reversed‐phase liquid chromatography coupled to electrospray ionization mass spectrometryBiomedical Chromatography, 2003
- Tolerability of memantine in combination with cholinesterase inhibitors in dementia therapyInternational Clinical Psychopharmacology, 2003
- Kinetic and Structural Studies on the Interaction of Cholinesterases with the Anti-Alzheimer Drug Rivastigmine,Biochemistry, 2002
- Lack of adverse pharmacodynamic drug interactions with rivastigmine and twenty-two classes of medicationsInternational Journal of Geriatric Psychiatry, 2000
- Alzheimer's diseaseNeurology, 1998
- Pharmacologic treatment of cognition in Alzheimer's dementiaNeurology, 1998
- Glutamate Transporter Alterations in Alzheimer Disease Are Possibly Associated with Abnormal APP ExpressionJournal of Neuropathology and Experimental Neurology, 1997
- Prophylactic and therapeutic efficacy of memantine against seizures produced by soman in the ratToxicology and Applied Pharmacology, 1992
- Prevention and antagonism of acute carbofuran intoxication by memantine and atropineJournal of Toxicology and Environmental Health, 1989
- A new and rapid colorimetric determination of acetylcholinesterase activityBiochemical Pharmacology, 1961